| Subject | Predicate | Object | Context |
|---|---|---|---|
| pubmed-article:1935964 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1935964 | lifeskim:mentions | umls-concept:C0205103 | lld:lifeskim |
| pubmed-article:1935964 | lifeskim:mentions | umls-concept:C0004002 | lld:lifeskim |
| pubmed-article:1935964 | lifeskim:mentions | umls-concept:C0039476 | lld:lifeskim |
| pubmed-article:1935964 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:1935964 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1935964 | pubmed:dateCreated | 1991-11-26 | lld:pubmed |
| pubmed-article:1935964 | pubmed:abstractText | Absorption and circular dichroism spectra of stable enzyme-substrate intermediates of aspartate aminotransferase were recorded at subzero temperatures (down to -65 degrees C) in the cryosolvent water/methanol. The intermediates were formed either between the pyridoxal form of the enzyme and its amino acid substrates, or between the pyridoxamine form and its oxo acid substrates. Kd values determined by spectroscopic titration were very close to the Km values reported for the different substrates. The adsorption complex of the pyridoxal form was probably obtained on addition of cysteine sulfinate. This complex is characterized by an increased absorption at 430 nm together with a positive Cotton effect, as also observed in the case of the complex with the competitive inhibitor maleate indicating protonation of the internal aldimine. Addition of the substrates aspartate or glutamate to the pyridoxal form seemed to result in the direct accumulation of the external aldimine which showed a slight decrease in both the absorbance and the Cotton effect at 360 nm. Additionally, a bathochromic shift of 5 nm was observed in the case of glutamate. At 430 nm, only a minor increase in absorbance, but not in circular dichroism, was observed with aspartate, and no changes were found with glutamate and the substrate analog 2-methylaspartate, indicating a deprotonated external aldimine. Presumably, the ketimine intermediate was obtained on addition of the oxo acids 2-oxoglutarate or oxalacetate to the pyridoxamine form. The intermediate showed a slight bathochromic shift (2 nm) of the absorption band and decreased circular dichroism. On formation of the ketimine, a tyrosine residue, probably active-site Tyr225, becomes partly ionized. The finding that the external aldimine can probably be accumulated in the conversion of the pyridoxal to the pyridoxamine form with the natural substrates would confirm the proton abstraction at C alpha to be the rate-limiting step in the tautomerization, although with cysteine sulfinate, the formation of the external aldimine might contribute to the rate limitation. Accumulation of the ketimine in the reverse direction would indicate that the proton abstraction at C4' is rate-limiting in this half-reaction. The results demonstrate the feasibility of further structural investigations of true enzyme-substrate intermediates. | lld:pubmed |
| pubmed-article:1935964 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1935964 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1935964 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1935964 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1935964 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1935964 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:1935964 | pubmed:issn | 0014-2956 | lld:pubmed |
| pubmed-article:1935964 | pubmed:author | pubmed-author:StereGG | lld:pubmed |
| pubmed-article:1935964 | pubmed:author | pubmed-author:GehringHH | lld:pubmed |
| pubmed-article:1935964 | pubmed:issnType | lld:pubmed | |
| pubmed-article:1935964 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:1935964 | pubmed:volume | 201 | lld:pubmed |
| pubmed-article:1935964 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1935964 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1935964 | pubmed:pagination | 703-7 | lld:pubmed |
| pubmed-article:1935964 | pubmed:dateRevised | 2007-7-23 | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:meshHeading | pubmed-meshheading:1935964-... | lld:pubmed |
| pubmed-article:1935964 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1935964 | pubmed:articleTitle | Spectroscopic characterization of true enzyme-substrate intermediates of aspartate aminotransferase trapped at subzero temperatures. | lld:pubmed |
| pubmed-article:1935964 | pubmed:affiliation | Biochemisches Institut, Universität Zürich, Switzerland. | lld:pubmed |
| pubmed-article:1935964 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1935964 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |